ByTrending Posts
Can Eli Lilly’s 2025 Brand Launches and Label…
Global | January 2026 — Eli Lilly and Company accelerated its transformation in 2025 through a series of…
Can Pfizer’s 2025 Brand Launches Across Vaccines, Oncology,…
Global | January 2026 — Pfizer Inc. advanced its post-pandemic transformation in 2025 through a series of targeted…
Will Merck’s $9.2 Billion Acquisition of Cidara Therapeutics…
Rahway, NJ & San Diego, CA | January 2026 Merck & Co., Inc. has confirmed that its approximately…
Can Insilico Medicine’s Hong Kong IPO Signal a…
Hong Kong | January 4, 2026 Insilico Medicine, a China-based, AI-driven drug discovery company backed by Qiming Venture…
Is AI Now Shaping the Future of Biopharma…
Executive Summary A recent Endpoints Signal Pulse Report reveals that half of biopharma professionals now consider themselves heavy…
Is Butterfly Network Using AI and Handheld Imaging…
Executive Summary Butterfly Network is pioneering AI-enabled, handheld ultrasound devices designed to make imaging more accessible, affordable, and…
Is Canon Medical Systems Using AI to Transform…
Executive Summary Canon Medical Systems is advancing the integration of artificial intelligence, automated analytics, and cloud-enabled imaging solutions…
Is Siemens Healthineers Using AI to Transform Diagnostics,…
Executive Summary Siemens Healthineers, a global leader in medical technology, is accelerating the adoption of AI-driven solutions across…
Can GE Healthcare Integrate AI Across Imaging, Monitoring,…
Headline Summary GE Healthcare, a global leader in medical technology, is driving the next wave of healthcare innovation…
Trending Posts
Latest Stories
Despite Geopolitical Tensions, U.S.–China Biotech Interdependence Remains Central
23 January 2026 Executive Summary Industry reports continue to underscore the deep interdependence between U.S.…
Are China’s Innovation and Cost Advantages Redrawing Global Biopharma Competition?
23 January 2026 Executive Summary Competitive dynamics across global biopharma in 2026 are being fundamentally…
Is China Outpacing the Global Biopharma Cycle? Innovation and Deal Momentum Accelerate
23 January 2026 Executive Summary China’s biopharma sector is continuing to advance at remarkable speed,…
Is China Becoming a Power Center for AI-Led Drug Discovery? Insilico Medicine Strikes $66 Million NLRP3 Licensing Deal
23 January 2026 Executive Summary Artificial-intelligence-driven drug developer Insilico Medicine has entered into a $66…
Gallery
